Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02689921
Title NEOADjuvant Aromatase Inhibitor and Pertuzumab/Trastuzumab for Women With Breast Cancer (NEOADAPT)
Acronym NEOADAPT
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Midwestern Regional Medical Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Southeastern Regional Medical Center Newnan Georgia 30265 United States Details
Cancer Treatment Centers of America at Midwestern Regional Medical Center Zion Illinois 60099 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field